
Sign up to save your podcasts
Or


Spinogenix Founder and CEO Stella Sarraf sits with ForbesWomen Editor Maggie McGrath at the Nasdaq MarketSite to discuss her company's novel approach to treating neurodegenerative disease at the synaptic level.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Forbes Media LLC4.8
66 ratings
Spinogenix Founder and CEO Stella Sarraf sits with ForbesWomen Editor Maggie McGrath at the Nasdaq MarketSite to discuss her company's novel approach to treating neurodegenerative disease at the synaptic level.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

11,249 Listeners

4,181 Listeners

1,720 Listeners

4,362 Listeners

401 Listeners

426 Listeners

1,654 Listeners

672 Listeners

1,450 Listeners

1,050 Listeners

187 Listeners

505 Listeners

1,301 Listeners

6,088 Listeners

758 Listeners

14 Listeners

3 Listeners